Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Jason Gerberry
Recent news which mentions Jason Gerberry
Xenon Pharmaceuticals May Have A Blockbuster Drug In Store, BofA Says
August 29, 2022
Tickers
XENE
Tags
Analyst Ratings
Market News
Initiation
From
Benzinga
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate'
August 05, 2022
Tickers
TEVA
Tags
Jason Gerberry
Analyst Color
TEVA
From
Benzinga
Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical
June 27, 2022
Tickers
AXSM
Tags
Jason Gerberry
News
FDA
From
Benzinga
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
May 17, 2022
Tickers
TEVA
Tags
Health Care
Benzinga
opiods
From
Benzinga
BofA Initiates Arcellx With Buy On Its Novel Therapy Approach
March 01, 2022
Tickers
ACLX
Tags
Analyst Color
Jason Gerberry
Benzinga
From
Benzinga
BofA Downgrades Ionis After Vupanorsen Setback: Are There Upcoming Catalysts That Can Help The Stock?
February 01, 2022
Tickers
IONS
Tags
Analyst Ratings
Price Target
Market News
From
Benzinga
BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway'
September 02, 2021
Tickers
ALKS
Tags
Analyst Color
Downgrades
ALKS
From
Benzinga
FibroGen Analyst Removes Roxadustat Sales From Model After AdCom Snub
July 16, 2021
Tickers
FGEN
Tags
Benzinga
Movers
FDA
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.